Kingswood Wealth Advisors LLC Acquires Shares of 21,622 BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Kingswood Wealth Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the second quarter, HoldingsChannel reports. The fund acquired 21,622 shares of the company’s stock, valued at approximately $355,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Sunbelt Securities Inc. acquired a new stake in BlackRock Health Sciences Term Trust in the first quarter worth $28,000. MUFG Americas Holdings Corp acquired a new stake in BlackRock Health Sciences Term Trust in the third quarter worth $30,000. Benjamin F. Edwards & Company Inc. raised its holdings in BlackRock Health Sciences Term Trust by 677.8% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 3,967 shares of the company’s stock worth $66,000 after purchasing an additional 3,457 shares during the period. Harbour Investments Inc. acquired a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth $89,000. Finally, Icon Wealth Partners LLC acquired a new stake in BlackRock Health Sciences Term Trust in the first quarter worth $105,000.

BlackRock Health Sciences Term Trust Trading Up 1.2 %

BMEZ opened at 13.62 on Wednesday. The firm’s fifty day moving average is 14.03 and its two-hundred day moving average is 15.37. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 17.05.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be issued a $0.0927 dividend. The ex-dividend date is Tuesday, November 14th. This represents a $1.11 annualized dividend and a yield of 8.17%.

Insiders Place Their Bets

In related news, major shareholder Saba Capital Management, L.P. acquired 22,167 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average cost of 13.48 per share, for a total transaction of 298,811.16. Following the completion of the acquisition, the insider now directly owns 12,692,044 shares in the company, valued at approximately 171,088,753.12. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last three months, insiders have bought 924,636 shares of company stock worth $12,490,378.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.